Seiichiro Kusuhara

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · PLoS ONE · 2019 · 39 citations · Full text

Prognostic significance of NAP1L1 expression in patients with early lung adenocarcinoma

Ryo Nagashio, Yuki Kuchitsu, Satoshi Igawa et al. · Biomedical Research · 2020 · 33 citations · Full text

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

Masayuki Shirasawa, Tomoya Fukui, Seiichiro Kusuhara et al. · Cancer Management and Research · 2018 · 28 citations · Full text

<p>Impact of <em>EGFR </em>genotype on the efficacy of osimertinib in <em>EGFR </em>tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study</p>

Satoshi Igawa, Taihei Ono, Masashi Kasajima et al. · Cancer Management and Research · 2019 · 23 citations · Full text

First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study

Satoshi Igawa, Tomoya Fukui, Masashi Kasajima et al. · Investigational New Drugs · 2021 · 21 citations

Medicine, Prospective Observational Study, Pathology +9